Ozempic Maker Novo Nordisk Suffers Massive Fire in Denmark

Novo Nordisk A/S, the maker of Ozempic and Wegovy, lost an office building at its Danish headquarters complex due to a massive fire, in the second blaze to hit the drugmaker in less than a week.

The fire is now under control, though the building is “not able to be saved,” a Novo spokesperson said by email on Wednesday. The location isn’t used for production and the main headquarters building was not affected, Novo said.

Read: Ozempic Maker Novo Nordisk Has Denmark’s Economy Hooked

Its weight-loss and diabetes treatments have transformed Novo into Europe’s most valuable company, and the ...